Reviews in the Neurosciences · 2020 · 28 citations · 93 references
MedicinePharmacologyPharmacotherapyEpilepsyEpileptologyNeuropharmacologyAntiepileptic PharmacologyAntiepileptic PharmacotherapyAntiseizure MedicationsNeuroprotectionNeuroprotective PharmacologyMechanismsMelatonin PharmacologyMelatonin TreatmentNeuroprotective AgentsNeuroprotective PharmacotherapyNew Antiseizure Drug DevelopmentNovel Antiseizure MedicationsPharmacodynamics Of Antiseizure Medications
Extensive research has gone into proposing a promising link between melatonin administration and attenuation of epileptic activity, the majority of which suggest its propensity as an antiseizure with antioxidant and neuroprotective properties. In the past few years, a number of studies highlighting the association of the melatonergic ligands with epilepsy have also emerged. In this context, our review is based on discussing the recent studies and various mechanisms of action that the said category of drugs exhibit in the context of being therapeutically viable antiseizure drugs. Our search revealed several articles on the four major drugs i.e. melatonin, agomelatine, ramelteon and piromelatine along with other melatonergic agonists like tasimelteon and TIK-301. Our review is suggestive of antiseizure effects of both melatonin and its analogues; however, extensive research work is still required to study their implications in the treatment of persons with epilepsy. Further evaluation of melatonergic signaling pathways and mechanisms may prove to be helpful in the near future and might prove to be a significant advance in the field of epileptology.
93
Ingrid E. Scheffer, Samuel F. Berkovic, Giuseppe Capovilla et al. · Epilepsia · 2017 · 4.9K citations · Full text
Mark J. Millan, Alain P. Gobert, F. Lejeune et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 512 citations · Full text
Takashi Sugawara, Yuji Tsurubuchi, Kishan Agarwala et al. · Proceedings of the National Academy of Sciences · 2001 · 379 citations · Full text
Life Sciences, Genetics, Neurology +17